Asia Pacific Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Country and Growth Forecast, 2022

List of Tables

The Asia Pacific Human Microbiome Market would witness market growth of 33.2% CAGR during the forecast period (2022-2028).

The human microbiome plays a vital role in the body's maintenance and development. In neonates and young children, these organisms are fundamental for activating the immune system, altering inflammatory homeostasis and immunological control. Children who acquire allergies later in life have a higher prevalence of anaerobic bacteria and Bacteroidaceae, as well as a lower count of Bifidobacterium bifidum, Bifidobacterium adolescentis, and Lactobacillus spp. These organisms engage with and digest external pollutants such as polycyclic aromatic hydrocarbons, heavy metals, herbicides, ochratoxins, organic chemicals, and plastic monomers. Toxins cleared from the bloodstream by renal filtration are retained in the bladder, which provides substrates and a favorable environment for the urinary tract microbiota to break down hazardous compounds. The interactions between these species influence the outcome of an infection. Indigenous microbial flora, which is responsible for initiating innate immunity, including secretions including cytokines, antimicrobial peptides, and inhibitory compounds, initiates the protective mechanism in the female genital tract.

The prevalence of diabetes is rapidly rising in this region. According to the World Health Organization, diabetes affects over 10% of all adults in China or approximately 110 million individuals. Without an immediate effort to address lifestyle risk factors, such as poor food as well as lack of physical activity, that number is likely to rise to 150 million by 2040, causing serious health, social, and economic implications. Various initiatives are being taken by the government in order to tackle the situation, for example, Beat Diabetes. This provides a chance to consider the causes of the disease's rising prevalence in China, as well as what might be done to reverse the trend. Type 1 diabetes, also known as juvenile diabetes, is characterized by a lack of insulin production and necessitates daily insulin injection. Type 1 diabetes has no recognized cause. The body's non-optimized utilization of insulin leads to type 2 diabetes. Type 2 diabetes affects 90% of diabetics is caused primarily by obesity and physical inactivity.

The China market dominated the Asia Pacific Human Microbiome Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $84.6 million by 2028. The Japan market is estimated to grow at a CAGR of 32.4% during (2022 - 2028). Additionally, The India market would witness a CAGR of 34% during (2022 - 2028).

Based on Product, the market is segmented into Drugs, Diagnostic Tests, Probiotics, Prebiotics, and Others. Based on Disease Type, the market is segmented into Infectious Diseases, Endocrine & Metabolic Disorders, Gastrointestinal Diseases, Cancer, and Others. Based on Technology, the market is segmented into Genomics, Proteomics and Metabolomics. Based on Application, the market is segmented into Therapeutics and Diagnostics. Based on Type, the market is segmented into Microbiome Consortia Transplantation (FMT), Peptide, Live Biotherapeutic Product and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Seres Therapeutics, Inc., 4D pharma plc, OptiBiotix Health Plc, Synlogic, Inc., Second Genome, Inc., Vedanta Biosciences, Inc., Finch Therapeutics Group, Inc., Ferring Holdings SA, and Enterome.

Scope of the Study

Market Segments covered in the Report:

By Product

Drugs
Diagnostic Tests
Probiotics
Prebiotics, and
Others

By Disease Type

Infectious Diseases
Endocrine & Metabolic Disorders
Gastrointestinal Diseases
Cancer, and
Others

By Technology

Genomics
Proteomics
Metabolomics

By Application

Therapeutics
Diagnostics

By Type

Microbiome Consortia Transplantation (FMT)
Peptide
Live Biotherapeutic Product
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

Seres Therapeutics, Inc.
4D pharma plc
OptiBiotix Health Plc
Synlogic, Inc.
Second Genome, Inc.
Vedanta Biosciences, Inc.
Finch Therapeutics Group, Inc.
Ferring Holdings SA
Enterome

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Human Microbiome Market, by Product
- 1.4.2 Asia Pacific Human Microbiome Market, by Disease Type
- 1.4.3 Asia Pacific Human Microbiome Market, by Technology
- 1.4.4 Asia Pacific Human Microbiome Market, by Application
- 1.4.5 Asia Pacific Human Microbiome Market, by Type
- 1.4.6 Asia Pacific Human Microbiome Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Asia Pacific Human Microbiome Market by Product

3.1 Asia Pacific Drugs Market by Country
3.2 Asia Pacific Diagnostic Tests Market by Country
3.3 Asia Pacific Probiotics Market by Country
3.4 Asia Pacific Prebiotics Market by Country
3.5 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Human Microbiome Market by Disease Type

4.1 Asia Pacific Infectious Diseases Market by Country
4.2 Asia Pacific Endocrine & Metabolic Disorders Market by Country
4.3 Asia Pacific Gastrointestinal Diseases Market by Country
4.4 Asia Pacific Cancer Market by Country
4.5 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Human Microbiome Market by Technology

5.1 Asia Pacific Genomics Market by Country
5.2 Asia Pacific Proteomics Market by Country
5.3 Asia Pacific Metabolomics Market by Country

Chapter 6. Asia Pacific Human Microbiome Market by Application

6.1 Asia Pacific Therapeutics Market by Country
6.2 Asia Pacific Diagnostics Market by Country

Chapter 7. Asia Pacific Human Microbiome Market by Type

7.1 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country
7.2 Asia Pacific Peptide Market by Country
7.3 Asia Pacific Live Biotherapeutic Product Market by Country
7.4 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Human Microbiome Market by Country

8.1 China Human Microbiome Market
- 8.1.1 China Human Microbiome Market by Product
- 8.1.2 China Human Microbiome Market by Disease Type
- 8.1.3 China Human Microbiome Market by Technology
- 8.1.4 China Human Microbiome Market by Application
- 8.1.5 China Human Microbiome Market by Type
8.2 Japan Human Microbiome Market
- 8.2.1 Japan Human Microbiome Market by Product
- 8.2.2 Japan Human Microbiome Market by Disease Type
- 8.2.3 Japan Human Microbiome Market by Technology
- 8.2.4 Japan Human Microbiome Market by Application
- 8.2.5 Japan Human Microbiome Market by Type
8.3 India Human Microbiome Market
- 8.3.1 India Human Microbiome Market by Product
- 8.3.2 India Human Microbiome Market by Disease Type
- 8.3.3 India Human Microbiome Market by Technology
- 8.3.4 India Human Microbiome Market by Application
- 8.3.5 India Human Microbiome Market by Type
8.4 South Korea Human Microbiome Market
- 8.4.1 South Korea Human Microbiome Market by Product
- 8.4.2 South Korea Human Microbiome Market by Disease Type
- 8.4.3 South Korea Human Microbiome Market by Technology
- 8.4.4 South Korea Human Microbiome Market by Application
- 8.4.5 South Korea Human Microbiome Market by Type
8.5 Singapore Human Microbiome Market
- 8.5.1 Singapore Human Microbiome Market by Product
- 8.5.2 Singapore Human Microbiome Market by Disease Type
- 8.5.3 Singapore Human Microbiome Market by Technology
- 8.5.4 Singapore Human Microbiome Market by Application
- 8.5.5 Singapore Human Microbiome Market by Type
8.6 Malaysia Human Microbiome Market
- 8.6.1 Malaysia Human Microbiome Market by Product
- 8.6.2 Malaysia Human Microbiome Market by Disease Type
- 8.6.3 Malaysia Human Microbiome Market by Technology
- 8.6.4 Malaysia Human Microbiome Market by Application
- 8.6.5 Malaysia Human Microbiome Market by Type
8.7 Rest of Asia Pacific Human Microbiome Market
- 8.7.1 Rest of Asia Pacific Human Microbiome Market by Product
- 8.7.2 Rest of Asia Pacific Human Microbiome Market by Disease Type
- 8.7.3 Rest of Asia Pacific Human Microbiome Market by Technology
- 8.7.4 Rest of Asia Pacific Human Microbiome Market by Application
- 8.7.5 Rest of Asia Pacific Human Microbiome Market by Type

Chapter 9. Company Profiles

9.1 Ferring Holdings SA
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research and Development Expense
- 9.1.5 Recent Strategies and Developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
- 9.2.1 Company Overview
- 9.2.2 Recent Strategies and Developments:
  - 9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Research & Development Expense
- 9.3.4 Recent Strategies and Developments:
  - 9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Research & Development Expense
- 9.4.4 Recent Strategies and Developments:
  - 9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
- 9.5.1 Company Overview
9.6 Synlogic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
- 9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
- 9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Research & Development Expense

LIST OF TABLES

TABLE 1 Asia Pacific Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 2 Asia Pacific Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 3 Asia Pacific Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 4 Asia Pacific Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 5 Asia Pacific Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 6 Asia Pacific Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 7 Asia Pacific Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 8 Asia Pacific Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 9 Asia Pacific Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 10 Asia Pacific Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 11 Asia Pacific Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 12 Asia Pacific Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 13 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 14 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 15 Asia Pacific Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 16 Asia Pacific Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 17 Asia Pacific Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 18 Asia Pacific Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 19 Asia Pacific Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 20 Asia Pacific Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 21 Asia Pacific Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 22 Asia Pacific Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 23 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 24 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 25 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 26 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 27 Asia Pacific Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 28 Asia Pacific Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 29 Asia Pacific Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 30 Asia Pacific Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 31 Asia Pacific Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 32 Asia Pacific Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 33 Asia Pacific Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 34 Asia Pacific Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 35 Asia Pacific Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 36 Asia Pacific Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 37 Asia Pacific Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 38 Asia Pacific Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 39 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 40 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 41 Asia Pacific Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 42 Asia Pacific Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 43 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 44 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 45 Asia Pacific Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 46 Asia Pacific Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 47 Asia Pacific Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 48 Asia Pacific Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 49 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 50 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 51 Asia Pacific Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 52 Asia Pacific Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 53 China Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 54 China Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 55 China Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 56 China Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 57 China Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 58 China Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 59 China Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 60 China Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 61 China Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 62 China Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 63 China Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 64 China Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 65 Japan Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 66 Japan Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 67 Japan Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 68 Japan Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 69 Japan Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 70 Japan Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 71 Japan Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 72 Japan Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 73 Japan Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 74 Japan Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 75 Japan Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 76 Japan Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 77 India Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 78 India Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 79 India Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 80 India Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 81 India Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 82 India Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 83 India Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 84 India Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 85 India Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 86 India Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 87 India Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 88 India Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 89 South Korea Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 90 South Korea Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 91 South Korea Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 92 South Korea Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 93 South Korea Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 94 South Korea Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 95 South Korea Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 96 South Korea Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 97 South Korea Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 98 South Korea Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 99 South Korea Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 100 South Korea Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 101 Singapore Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 102 Singapore Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 103 Singapore Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 104 Singapore Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 105 Singapore Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 106 Singapore Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 107 Singapore Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 108 Singapore Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 109 Singapore Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 110 Singapore Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 111 Singapore Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 112 Singapore Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 113 Malaysia Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 114 Malaysia Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 115 Malaysia Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 116 Malaysia Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 117 Malaysia Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 118 Malaysia Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 119 Malaysia Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 120 Malaysia Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 121 Malaysia Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 122 Malaysia Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 123 Malaysia Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 124 Malaysia Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 125 Rest of Asia Pacific Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 126 Rest of Asia Pacific Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 127 Rest of Asia Pacific Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 128 Rest of Asia Pacific Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 129 Rest of Asia Pacific Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 130 Rest of Asia Pacific Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 131 Rest of Asia Pacific Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 132 Rest of Asia Pacific Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 133 Rest of Asia Pacific Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 134 Rest of Asia Pacific Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 135 Rest of Asia Pacific Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 136 Rest of Asia Pacific Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 137 key information - Ferring Holdings SA
TABLE 138 Key information - Enterome
TABLE 139 KEY INFORMATION - Seres Therapeutics, Inc.
TABLE 140 Key Information - 4D pharma plc
TABLE 141 key Information - OptiBiotix Health Plc
TABLE 142 Key Information - Synlogic, Inc.
TABLE 143 Key Information - Second Genome, Inc.
TABLE 144 Key Information - Vedanta Biosciences, Inc.
TABLE 145 key information - Finch Therapeutics Group, Inc.

List of Figures

FIG 1 Methodology for the research

Asia Pacific Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents